Substituted pyrrolidine compounds useful as neuraminidase inhibitors

US6518299B1 · kind B1 · utility

Assignee

• BioCryst Pharmaceuticals, Inc. · US

Inventors

• Pooran Chand · Birmingham, US
• Pravin L. Kotian · Hoover, US
• Yarlagadda S. Babu · Birmingham, US
• John A. Montgomery · Birmingham, US

Key dates

• Filing date: Oct 20, 2000
• Grant date: Feb 11, 2003
• Expiry date: Oct 20, 2020

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D207/16
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Certain substituted pyrrolidine compounds, pharmaceutically acceptable salts thereof, and their method of preparation are disclosed as well as use as influenza virus neuraminidase inhibitors.